Specific spatial distribution patterns of tumor foci are associated with a low risk of biochemical recurrence in pT2pN0R0 prostate cancer

[1] Berger AP(2003)Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens Prostate 57 93-98

[2] Spranger R(2010)Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer BJU Int 106 1623-1627

[3] Kofler K(2009)Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy J Urol 182 2291-2295

[4] Steiner H(2004)Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma Cancer 100 2573-2576

[5] Bartsch G(2006)Substaging pathologically organ confined (pT2) prostate cancer: an exercise in futility? Eur Urol 49 209-211

[6] Horninger W(2009)Prognostic significance of prostate cancer originating from the transition zone Urol Oncol 27 592-597

[7] Caso JR(2007)Implementation of a map in radical prostatectomy specimen allows visual estimation of tumor volume Eur J Surg Oncol 33 352-357

[8] Tsivian M(2008)Guidelines for the macroscopic processing of radical prostatectomy and pelvic lymphadenectomy specimens J Clin Pathol 61 713-721

[9] Mouraviev V(2005)The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma Am J Surg Pathol 29 1228-1242

[10] Polascik TJ(2010)Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens BMC Med Inform Decis Mak 10 71-3.1.8

[1] Berger AP(2003)Early detection of prostate cancer with low PSA cut-off values leads to significant stage migration in radical prostatectomy specimens Prostate 57 93-98

[2] Spranger R(2010)Pathological T2 sub-divisions as a prognostic factor in the biochemical recurrence of prostate cancer BJU Int 106 1623-1627

[3] Kofler K(2009)Pathological stage T2 subgroups to predict biochemical recurrence after prostatectomy J Urol 182 2291-2295

[4] Steiner H(2004)Does pT2b prostate carcinoma exist? Critical appraisal of the 2002 TNM classification of prostate carcinoma Cancer 100 2573-2576

[5] Bartsch G(2006)Substaging pathologically organ confined (pT2) prostate cancer: an exercise in futility? Eur Urol 49 209-211

[6] Horninger W(2009)Prognostic significance of prostate cancer originating from the transition zone Urol Oncol 27 592-597

[7] Caso JR(2007)Implementation of a map in radical prostatectomy specimen allows visual estimation of tumor volume Eur J Surg Oncol 33 352-357

[8] Tsivian M(2008)Guidelines for the macroscopic processing of radical prostatectomy and pelvic lymphadenectomy specimens J Clin Pathol 61 713-721

[9] Mouraviev V(2005)The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma Am J Surg Pathol 29 1228-1242

[10] Polascik TJ(2010)Clinical map document based on XML (cMDX): document architecture with mapping feature for reporting and analysing prostate cancer in radical prostatectomy specimens BMC Med Inform Decis Mak 10 71-3.1.8